us-abim MCQ (SBA): VTE-Extended Therapy

Instant feedback + full explanation. One question, done properly.

ModerateHematologyVTE-Extended Therapyus-abimus-usmle-step-2us-usmle-step-3

A 67-year-old with prior unprovoked PE completed 3 months of apixaban and has low bleeding risk. He is considering reduced-dose secondary prevention. Which strategy is acceptable?

Educational content. Not a substitute for clinical judgement or local policy.

us-abim MCQ: VTE-Extended Therapy — Answer & Explanation | iatroX